Cambridge Antibody&#39;s Underdog Story
301149
Cambridge Antibody Technology&#39;s (Nasdaq: CATG) legal victory over Abbott Laboratories (NYSE: ABT) shows that a biotech David can triumph over a pharmaceutical Goliath.
365481
Researchers develop a new protein test that could one day take the guess-work out of making a diagnosis
145474
Looking over all the biotech stock stories I covered in 2004, I&#39;m pleased to report that I was right more than wrong. My &quot;win&quot; column does veer in the bearish direction, which is not ideal (I&#39;d prefer more
717545
A blood test on expectant mothers may predict a baby&#39;s risk of sudden infant death syndrome (SIDS), suggests a new research. According to The New Scientist, researches at the University of Cambridge have found
20646
The journal affirmed the validity of the report, which seemed to undercut the argument of stem-cell opponents.
260392
LONDON (CBS.MW) -- UK biotech Cambridge Antibody Technology (CATG) (UK:CAT) shares were suspended in London Monday amid a court decision.
336171
YESTERDAY Close $75.73 Change +$2.22 52-WEEK High $76.90 Low $58.71 Genzyme Corp. of Cambridge said profit jumped tenfold as sales increased for its medicines for rare genetic disorders, some of the world's costliest drugs. The company gained 3 percent in New York trading.
662969
Les donnÃ©es indiquent une augmentation de la rÃ©ponse sÃ©rologique, virologique et biochimique aprÃ¨s 144 semaines de traitement sur des patients naÃ¯fs atteints de l&#39;hÃ©patite B antigÃ¨ne positif.
631783
UK biotech company Cambridge Antibody Technology (CAT) has won its court fight for bigger royalties from the sale of arthritis medicine Humira.
754810
Cambridge Antibody Technology Group Plc won a court ruling awarding it higher royalties from US partner Abbott Laboratories for its role in developing one of the biggest drugs to come from the UK&#39;s biotechnology industry.
421686
Five years ago, Portland&#39;s Dr. Brian Druker told a gathering of blood scientists about a few dozen cancer patients who were taking an obscure new drug with surprising success.
665986
There&#39;s been a fair amount of debate recently about whether AMD or Intel is winning the ever-present chip arms race. Based on the experience of this year&#39;s Intel Developer Forum (IDF), I&#39;m not sure that Intel can still claim to be in the lead.
93775
Encouraging phase II results of a trial to test the efficacy of a malaria vaccine for young children is published in this week&#39;s issue of THE LANCET (pp 1380, 1411).
112584
Medarex (Nasdaq: MEDX) is best known for being a leader in antibody technology with its capabilities for generating human antibodies in mice.
640929
Shares of Cambridge-based Genzyme were up slightly today on news that the drug maker won approval for a drug to treat childhood leukemia.
424340
A small study shows its cancer treatment is comparable to others in terms of usefulness. Safety data is unknown.
49962
Word of a US Supreme Court justice&#39;s battle with cancer raises curiosity about a type of the disease we hear little about. There&#39;s not a lot of information on the degree of Chief Justice William Rehnquist&#39;s